Shreedhar Vijay 4
4 · Adamas Pharmaceuticals Inc · Filed Feb 1, 2021
Insider Transaction Report
Form 4
Shreedhar Vijay
Chief Commercial Officer
Transactions
- Sale
Common Stock
2021-02-01$6.39/sh−4,514$28,844→ 95,486 total
Footnotes (3)
- [F1]Pursuant to the mandatory sale to cover withholding tax requirements of the issuer's equity incentive plan, the shares were sold to cover the tax obligation realized upon the vesting of restricted stock units.
- [F2]The shares were sold at prices ranging from $6.36 to $6.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Includes 2,500 shares purchased on 5/31/2020 and 2,500 shares purchased on 11/30/2020 through the issuer's employee stock purchase plan.